DPYSL2 and Behcet disease: This study, in combination with our previous findings using hiPSC-derived neurons from healthy controls and BD patients15, demonstrates that lithium treatment at physiologically relevant levels decreases the abundance of the inactivated form of CRMP2, p-CRMP2T514, without decreasing total and unphosphorylated CRMP2.